Skip to main content

and
  1. No Access

    Article

    The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety Assessments

    Health technology assessment (HTA) is a multidisciplinary process that determines the value of health technology at different points in its lifecycle. Safety issues have become more important since regulatory ...

    Wen-Wen Yang, Yi-Chen Juan, Grace Hui-Min Wu, Raoh-Fang Pwu in Drug Safety (2024)

  2. Article

    Open Access

    Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

    Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statemen...

    Don Husereau, Michael Drummond in The European Journal of Health Economics (2022)

  3. Article

    Open Access

    Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

    Don Husereau, Michael Drummond in Applied Health Economics and Health Policy (2022)

  4. Article

    Open Access

    Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

    Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statemen...

    Don Husereau, Michael Drummond, Federico Augustovski in PharmacoEconomics (2022)

  5. Article

    Open Access

    Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

    Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statemen...

    Don Husereau, Michael Drummond in Applied Health Economics and Health Policy (2022)

  6. Article

    Open Access

    Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

    Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CH...

    Don Husereau, Michael Drummond, Federico Augustovski in BMC Public Health (2022)

  7. Article

    Open Access

    Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

    Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CH...

    Don Husereau, Michael Drummond, Federico Augustovski in BMC Health Services Research (2022)

  8. Article

    Open Access

    Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

    Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CH...

    Don Husereau, Michael Drummond, Federico Augustovski, Esther de Bekker-Grob in BMC Medicine (2022)

  9. Article

    Open Access

    Burden of asthma and COPD overlap (ACO) in Taiwan: a nationwide population-based study

    Patients with symptoms of both asthma and chronic obstructive pulmonary disease (COPD) may be classified with the term asthma-COPD overlap (ACO). ACO is of considerable interest as it is currently poorly chara...

    Sumitra Shantakumar, Raoh-Fang Pwu, Liesel D’Silva, Keele Wurst in BMC Pulmonary Medicine (2018)

  10. No Access

    Article

    Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?

    In October 2001, a pay-for-performance (P4P) program for diabetes was implemented by the National Health Insurance (NHI), a single-payer program, in Taiwan. However, only limited information is available rega...

    Elise Chia-Hui Tan, Raoh-Fang Pwu, Duan-Rung Chen in Quality of Life Research (2014)

  11. No Access

    Article

    Costs of cervical cancer and precancerous lesions treatment in a publicly financed health care system

    Although cervical cancer is the most frequent cancer for women in Taiwan, no examination of its treatment costs has yet been undertaken. This study aimed to investigate the costs of cervical cancer and precanc...

    Chao-Hsiun Tang, Raoh-Fang Pwu, I-Ching Tsai in Archives of Gynecology and Obstetrics (2010)